Biofrontera Inc. (NASDAQ:BFRI) Short Interest Update

Biofrontera Inc. (NASDAQ:BFRI) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 97,800 shares, a growth of 19.7% from the February 28th total of 81,700 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average daily volume of 384,300 shares, the days-to-cover ratio is presently 0.3 days.

Biofrontera Trading Up 0.3 %

Shares of Biofrontera stock opened at $0.80 on Thursday. The business’s 50-day moving average price is $1.01 and its 200-day moving average price is $1.01. The firm has a market capitalization of $7.11 million, a PE ratio of -0.35 and a beta of 0.30. Biofrontera has a 12 month low of $0.65 and a 12 month high of $2.43.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of BFRI. Rosalind Advisors Inc. lifted its holdings in shares of Biofrontera by 63.9% in the 4th quarter. Rosalind Advisors Inc. now owns 811,918 shares of the company’s stock worth $885,000 after acquiring an additional 316,428 shares during the last quarter. AIGH Capital Management LLC raised its position in Biofrontera by 61.8% in the 4th quarter. AIGH Capital Management LLC now owns 811,097 shares of the company’s stock worth $884,000 after purchasing an additional 309,663 shares during the period. Finally, Virtu Financial LLC purchased a new position in Biofrontera in the 4th quarter worth $48,000. 10.08% of the stock is currently owned by institutional investors.

About Biofrontera

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.